AI-Designed 'Intrabodies' Could Unlock New Treatments for Alzheimer's, Parkinson's and MND

Researchers have developed a breakthrough technology that transforms ordinary antibodies into tiny intracellular disease-fighting molecules, offering promising new therapeutic pathways for neurodegenerative diseases. This AI-designed approach enables these 'intrabodies' to work inside human cells, targeting disease-causing proteins that were previously difficult to reach with conventional treatments. The innovation specifically shows potential for treating Alzheimer's disease, Parkinson's disease, Huntington's disease, and motor neurone disease—conditions that currently lack effective cures. By leveraging artificial intelligence to engineer these molecular tools, scientists have overcome a major barrier in drug delivery, as most antibodies cannot naturally penetrate cell membranes. This advancement could revolutionize treatment options for millions of patients worldwide suffering from these devastating neurological conditions.